Therapeutic Action
Intermediate-acting pancreatic antidiabetic hormone mixed with protamine, in order to prolong the duration of activity
PDF page 425
Drug reference
Intermediate-acting pancreatic antidiabetic hormone mixed with protamine, in order to prolong the duration of activity
PDF page 425
Diabetes
PDF page 425
See "insulin: general information". Do not administer if known allergy to protamine. In the event of combination with short-acting insulin, always prepare the mix in the syringe immediately before administration and in the following order: first draw the short-acting insulin then the intermediate-acting insulin.
PDF page 425
1000 IU of insulin suspension in 10 ml vial (100 IU/ml) for deep SC injection (abdomen, thigh, buttock or arm), administered with a syringe calibrated in insulin units for U-100 insulin (100 IU/ml). NEVER ADMINISTER BY IV INJECTION.
PDF page 425
Child and adult: one to 2 injections daily in combination with short-acting insulin or metformine Dosage must be individualised according to need. Adapt dose in the event of physical activity, change in diet or infection.
PDF page 425
After removing vial from the refigerator, leave to reach room temperature. Shake the vial gently before use.
PDF page 425
– Do not freeze. Unopened vial: to be kept refrigerated (2 °C to 8 °C) Opened vial: max. 4 weeks at below 25 °C and protected from light.
PDF pages 425, 426
one to 2 injections daily in combination with short-acting insulin or metformine
PDF page 425